Literature DB >> 12640685

Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites.

Kari Hemminki1, Hong Zhang, Kamila Czene.   

Abstract

We studied incidence trends, age-incidence relationships and familial risks in invasive and in situ cutaneous melanoma, based on the Swedish Family-Cancer Database of more than 10 million individuals. Offspring were 0-66 years of age. Cancers were obtained from the Swedish Cancer Registry from years 1961-98. The study was based on 9,771 offspring and 22,888 parents with invasive melanoma and 2,446 offspring and 5,017 parents with in situ melanoma. Incidence rates increased markedly for invasive melanoma in the trunk. For in situ melanoma, trunk and head and neck were affected, and, in addition, legs for women. The maximal incidence was around age 80 years, independent of the type or site in men; in women early onset superficially spreading melanoma shifted the age for maximal incidence to about 60 years. For in situ melanoma, lentigo maligna was the main histogenetic type in the head and neck but in the trunk and legs superficially spreading melanoma was somewhat more common. Standardized incidence ratios (SIR) were calculated for familial risk at exposed and covered sites. The combined familial risks for invasive and in situ melanoma were higher at covered (SIR 3.56 from parents) than sun-exposed (1.92 from parents) sites and they agreed when familiality was defined between parents and offspring or between siblings; the sibling SIRs were 3.90 at covered and 2.53 at exposed sites. The data suggest that the higher melanoma density at exposed sites masks familial effects. Furthermore, sun exposure does not appear to reinforce the familial effect. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12640685     DOI: 10.1002/ijc.10976

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Host risk factors, ultraviolet index of residence, and incident malignant melanoma in situ among US women and men.

Authors:  Andrew C Walls; Jiali Han; Tricia Li; Abrar A Qureshi
Journal:  Am J Epidemiol       Date:  2013-04-11       Impact factor: 4.897

2.  Primary Locations of Malignant Melanoma Lesions Depending on Patients’ Gender and Age

Authors:  Karolina Stanienda-Sokół; Natalia Salwowska; Martyna Sławińska; Katarzyna Wicherska-Pawłowska; Anna Lorenc; Dominika Wcisło-Dziadecka; Jerzy Wydmański; Wojciech Majewski
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

Review 3.  Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment.

Authors:  Hildur Helgadottir; Iara Rocha Trocoli Drakensjö; Ada Girnita
Journal:  Front Oncol       Date:  2018-06-12       Impact factor: 6.244

4.  Ten-year Follow-up Study of Grenz Ray Treatment for Lentigo Maligna and Early Lentigo Maligna Melanoma.

Authors:  Iara R T Drakensjö; Einar Rosen; Margareta Frohm Nilsson; Ada Girnita
Journal:  Acta Derm Venereol       Date:  2020-10-06       Impact factor: 3.875

5.  Melanoma incidence and mortality in Scotland 1979-2003.

Authors:  R M MacKie; C Bray; J Vestey; V Doherty; A Evans; D Thomson; M Nicolson
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.